slides · global inventory
Paragraph
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 118,471
Current window 96,361-96,390
Pages 3,950
Rows per page 30
Component
96,361-96,390 of 118,471
03
The slide uses a silhouette of a person with molecular/cellular imagery inside to represent the focus on oncology.AstraZeneca | Investor Conference Presentation Deck | 20 slides · AstraZeneca
Conference presentation Investor relations Beat · Interest1 hit
04
AstraZeneca at #AACR23, slide 4.AstraZeneca | Investor Conference Presentation Deck | 20 slides · AstraZeneca
Conference presentation Investor relations Beat · InterestLoop · Cost Of Inaction1 hit
06
Includes Kaplan-Meier EFS curve and pCR bar chart with associated statistical table.AstraZeneca | Investor Conference Presentation Deck | 20 slides · AstraZeneca
Conference presentation Investor relations Beat · Interest1 hit
07
The slide uses a scientific illustration of an antibody binding to a cell membrane as a visual metaphor for the ADC technology.AstraZeneca | Investor Conference Presentation Deck | 20 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Jobs To Be Done1 hit
08
The slide uses a combination of technical explanation and a process diagram to define the technology.AstraZeneca | Investor Conference Presentation Deck | 20 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Jobs To Be Done1 hit
09
Includes a testimonial from Puja Sapra and a list of pipeline assets.AstraZeneca | Investor Conference Presentation Deck | 20 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Jobs To Be Done1 hit
10
Includes mechanism of action diagram and four tumor volume growth inhibition charts.AstraZeneca | Investor Conference Presentation Deck | 20 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Jobs To Be Done1 hit
11
The slide uses a before-after comparison of drug efficacy (MTI vs TOP1i) and a diagram of the ADC structure.AstraZeneca | Investor Conference Presentation Deck | 20 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Jobs To Be Done1 hit
13
Includes a quote from Mark Cobbold and a list of pipeline assets.AstraZeneca | Investor Conference Presentation Deck | 20 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
14
Includes a diagram of the CAR-T structure, a waterfall plot for C-CAR031, and a tumor volume line chart for AZD0754.AstraZeneca | Investor Conference Presentation Deck | 20 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
15
AstraZeneca branding at #AACR23 conference.AstraZeneca | Investor Conference Presentation Deck | 20 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
16
Includes a quote from Stephen Fawell and a diagram illustrating epigenetic mechanisms (histone modification, DNA methylation, RNA interference).AstraZeneca | Investor Conference Presentation Deck | 20 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
19
The slide acts as a summary of specific research presentations at AACR.AstraZeneca | Investor Conference Presentation Deck | 20 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
04
Includes a photo of the CEO and a scientific illustration of a virus/cell structure.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention1 hit
08
Includes a headshot of the CFO and a scientific illustration related to the company's field.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · Need1 hit
13
AstraZeneca | Results Presentation Deck | 41 slidesAstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
16
Includes Kaplan-Meier survival curves and bar charts for pCR rates.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
24
The slide features a portrait of the CEO and a scientific illustration of molecular structures.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
26
Includes a stacked bar chart for Soliris registry data and a trial design schematic for gefurulimab.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
28
AstraZeneca | Results Presentation Deck | 41 slidesAstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · Visualization1 hit
33
Includes progress against specific 2025/2026 targets.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations 1 hit
01
ATAI | Investor Presentation Deck | 30 slidesATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations 1 hit
08
Uses a timeline-style vertical flow to represent the 'need' metrics.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
10
The slide uses a vertical process flow to show the progression of clinical trials and data validation.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
12
The slide highlights that lower doses of RL-007 (40 or 80 mg TID) show statistically significant improvements compared to placebo in cognitive endpoints.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
13
The slide uses a standard clinical trial flow diagram to illustrate the study methodology.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
15
The slide uses a split-layout: left side defines the condition and market size, right side highlights the 'unaddressed need' (treatment gap, comorbidity, and lack of innovation).ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
16
The slide uses a split-layout with a left-hand summary table and a right-hand clinical data visualization.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
18
The slide uses topographical brain maps to visualize EEG data changes.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
20
The slide uses a checkmark matrix to highlight the competitive advantage of the drug candidate.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit